Abstract
Terbutaline and clenbuterol, which are both selective beta 2-adrenoceptor agonists, produced a concentration-dependent decrease in contractile force of in vitro rabbit detrusor and proximal urethral smooth muscle. Conversely, terbutaline and clenbuterol produced a concentration-dependent increase in basal tension of in vitro rabbit external urethral striated muscle. Clenbuterol, orally administrated, produced an increase in urinary bladder capacity in cystometry and also an increase in maximal urethral closure pressure in urethral pressure profile. These results suggest that the beta 2-adrenoceptor agonist may be beneficial for urinary incontinent patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
